Coherus BioSciences, Inc. (CHRS) Net Income (Loss) Attributable to Parent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Coherus BioSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $103 M.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$59.3 M, a 78.2% increase year-over-year.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$238 M, a 18.5% increase from 2022.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$292 M, a 1.62% decline from 2021.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$287 M, a 317% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$59.3 M $103 M +$179 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$238 M -$79.7 M -$20.8 M -35.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$217 M -$39.6 M +$47 M +54.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$264 M -$42.9 M +$7.28 M +14.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-06
Q1 2023 -$271 M -$75.7 M +$20.4 M +21.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$292 M -$58.9 M -$13.1 M -28.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$279 M -$86.7 M -$48.1 M -125% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$230 M -$50.2 M -$20.3 M -67.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$210 M -$96.1 M +$76.9 M +44.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$287 M -$45.7 M -$55.4 M -571% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$232 M -$38.5 M -$66.5 M -238% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$165 M -$29.9 M -$88.9 M -151% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$76.3 M -$173 M -$209 M -586% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 $132 M $9.71 M -$29.5 M -75.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $162 M $27.9 M -$19.1 M -40.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $181 M $59 M +$35.5 M +150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 $145 M $35.6 M +$55.6 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 $89.8 M $39.2 M +$102 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$12 M $47 M +$106 M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$118 M $23.6 M +$67.2 M Apr 1, 2019 Jun 30, 2019 10-Q 2019-11-08
Q1 2019 -$185 M -$20 M +$24.3 M +54.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$209 M -$62.6 M -$13.5 M -27.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$196 M -$58.8 M +$181 K +0.31% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$196 M -$43.6 M +$11.7 M +21.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$208 M -$44.3 M +$30.5 M +40.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$238 M -$49.1 M +$26.9 M +35.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$265 M -$59 M -$143 M -170% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$122 M -$55.3 M +$14.6 M +20.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$137 M -$74.8 M -$9.39 M -14.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$127 M -$75.9 M -$23.5 M -44.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$104 M $83.9 M +$155 M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$259 M -$70 M -$11.2 M -19% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$248 M -$65.4 M -$24.7 M -60.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$223 M -$52.4 M -$23.3 M -79.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$200 M -$71.3 M -$63.5 M -806% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$137 M -$58.8 M -$33.9 M -136% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$103 M -$40.7 M -$15.6 M -61.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$87.1 M -$29.1 M -$14.5 M -99.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$72.6 M -$7.87 M +$13.6 M +63.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$86.2 M -$25 M -$16.2 M -187% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$69.9 M -$25.2 M -$16.3 M -184% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$53.6 M -$14.6 M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 -$21.5 M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-23
Q2 2013 -$8.71 M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-23
Q1 2013 -$8.86 M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.